跳至主要内容
临床试验/NCT04513444
NCT04513444招募中2 期

Phase II Study Aiming to Evaluate the Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy

Institut Claudius Regaud2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2020年12月7日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
招募中
入组人数
45
试验地点
2
主要终点
Rate of patients with at least a 10-point decrease in anxiety score (evolution between the baseline and the 6th and last radiotherapy session)

研究概览

简要总结

This phase II, randomized, non-comparative and monocentric study aims to evaluate the interest of medical hypnosis in the management of anxiety in patients who are moderately anxious, anxious or very anxious during their radiotherapy treatment.

45 patients will be randomized into the following arms:

  • Arm A (standard): relaxation with music listening during radiotherapy treatment
  • Arm B (experimental): relaxation with music listening and hypnosis during radiotherapy treatment

For the study each patient will be followed during 2 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years at the time of enrollment into the study.
  • Patient with localized or metastatic solid malignant tumor.
  • Patient being followed for the cancer pathology at IUCT-O and to receive, for the first time in the follow-up, treatment by radiotherapy (radiotherapy treatment should not have been initiated prior to inclusion in the study).
  • Patient for whom radiotherapy treatment includes at least 15 sessions of radiation therapy.
  • Patient defined as moderately anxious, anxious or very anxious after completing the STAI-Y self-assessment questionnaire (i.e. ≥ 46 score at inclusion).
  • ECOG patient ≤
  • Patient who signed informed consent prior to inclusion in the study and prior to any specific study procedures.
  • Patient affiliated to a Social Health Insurance in France.

排除标准

  • Patient doesn't understand the French language.
  • Patient with psychiatric disorders requiring antidepressant or antipsychotic treatment.
  • Patient with hearing problems.
  • Pregnant or breastfeeding women.
  • Any psychological, family, geographical or sociological condition that prevents compliance with the medical follow-up and/or procedures of the study protocol.
  • Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

研究组 & 干预措施

Standard arm (A): music listening therapy

Other

干预措施: Relaxation with music listening during radiotherapy treatment: (Other)

Experimental arm (B): music listening and hypnosis therapy

Experimental

干预措施: Relaxation with music listening and medical hypnosis during radiotherapy treatment: (Other)

结局指标

主要结局

Rate of patients with at least a 10-point decrease in anxiety score (evolution between the baseline and the 6th and last radiotherapy session)

时间窗: 2 months for each patient

Anxiety will be assessed using the STAI-Y questionnaire (Spielberger State-Trait Anxiety Inventory - State Anxiety form).

次要结局

  • Quality of life assessed using the EORTC (European Organization for Research and Treatment of Cancer) Quality of life questionnaire (QLQ-C30).(2 months for each patient)
  • Anxiety assessed using a numerical scale from 0 to 10 (0 being "not at all anxious" and 10 being "extremely anxious")(2 months for each patient)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验